Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myotonic dystrophy.

R F Jozefowicz1, R C Griggs

  • 1Laboratory Medicine, University of Rochester School of Medicine and Dentistry, New York.

Neurologic Clinics
|August 1, 1988
PubMed
Summary
This summary is machine-generated.

Myotonic dystrophy is a genetic disorder causing muscle weakness and other symptoms. While the gene is known, the exact metabolic issues, potentially linked to insulin resistance in muscles, remain unclear.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monozygotic twins with facioscapulohumeral dystrophy (FSHD): implications for genotype/phenotype correlation.

Muscle & nerve. Supplement·2013
Same author

American Academy of Neurology policy on pharmaceutical and device industry support.

Neurology·2012
Same author

Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype.

Neurology·2011
Same author

Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties.

Neurology·2010
Same author

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Brain : a journal of neurology·2009
Same author

Muscle diseases.

Journal of clinical neuromuscular disease·2008

Area of Science:

  • Genetics
  • Neurology
  • Metabolic Disorders

Background:

  • Myotonic dystrophy is an autosomal dominant disorder.
  • It presents with skeletal muscle weakness, myotonia, and various non-muscular issues.
  • The specific metabolic abnormalities driving the disorder are currently unknown.

Purpose of the Study:

  • To summarize the current understanding of myotonic dystrophy.
  • To highlight the potential role of insulin resistance in muscle wasting.
  • To outline diagnostic and management strategies.

Main Methods:

  • Clinical evaluation and family history are primary diagnostic tools.
  • Laboratory studies like electromyography, electrocardiography, and muscle biopsy aid in assessment.
  • Review of existing literature on myotonic dystrophy.

Related Experiment Videos

Main Results:

  • Myotonic dystrophy affects skeletal muscles, causing weakness and wasting.
  • Skeletal muscle exhibits relative insulin resistance.
  • A decrease in insulin's anabolic action may contribute to muscle wasting.

Conclusions:

  • Clinical presentation and family history are crucial for diagnosing myotonic dystrophy.
  • Understanding metabolic abnormalities, particularly insulin resistance, is key.
  • Management strategies focus on preserving function and preventing complications.